Search

Issue
Title
Authors
New approaches to staging and treatment of primary endometrial cancer
Bakhidze E.V., Belyaeva A.V., Berlev I.V.
Prevalence of chronic kidney disease among cancer patients
Трофимцева Т.Н., Yarovoy S.K., Gritskevich A.A.
TIME COURSE AND PROGNOSIS OF BENIGN AND MALIGNANT TUMORS OF THE FEMALE REPRODUCTIVE SYSTEM ON THE BACKGROUND OF COMORBID CONDITIONS
Vertkin A.L., Kozlova O.V., Khashukoeva A.Z., Vertkin A., pl?midmagidsid h.h., Khashukoyeva A.Z.
Cardiac toxicity of fluoropyrimidines in the treatment of solid gastrointestinal tumors
Bogatyreva L.R., Besova N.S., Yunayev G.S., Kurmukov I.A., Obarevich E.S., Gavrilova D.A., Egorova A.V., Lepkova N.V., Tryakin A.A.
PARP inhibitors in a personalized approach to the treatment of castration-resistant prostate cancer: clinical case
Gritskevich A.A., Byteman T.P., Monakov D.M., Rusakov I.G., Mishugin S.V.
Evaluation of long-term results of treatment of patients with residual tumors (including those with minimal forms of ypT1abN0), with pathomorphological complete response (pCR) after neoadjuvant systemic therapy, with primary minimal breast cancer (pT1abN0M0)
Pesotsky R.S., Semiglazov V.F., Krivorotko P.V., Tabagua T.T., Zernov K.Y., Emelyanov A.S., Semiglazova T.Y., Amirov N., Mortada V.V., Ulrikh D.G., Levchenko V.E., Rychagov K.Y., Zirov K.Y., Evseev V.N.
The role of alpelisib in the treatment of PIK3CA - a mutated breast cancer
Semiglazov V.F., Krivorotko P.V., Komyakhov A.V., Semiglazova T.Y., Gigolaeva L.P., Tabagua T.T., Kazantseva M.D., Tergoeva A.P., Ulrikh D.G., Chervyak M.V., Klimenko V.V., Amirov N.S., Zhiltsova E.K., Semiglazov V.V.
The effect of drug therapy and cetuximab on the mutational status of the KRAS gene in patients with squamous cell carcinoma of the tongue and oral floor mucosa
Lyanova A.A., Vladimirova L.Y., Kutilin D.S., Abramova N.A., Popova I.L., Tikhanovskaya N.M., Teplyakova M.A., Novoselova K.A., Myagkova V.S., Alieva F.V., Ryadinskaya L.A.
Experience of the use of ixabepilone in polychemotherapy regimens for disseminated triple-negative breast cancer
Glazkova E.V., Frolova M.A., Menshikov S.F., Stenina M.B.
Perspektivy primeneniya kapsul vinorelbina v sovremennoy onkologii
Gutorov S.L., Stepanchenko M.V., Lichinitser M.R.
Eribulin – novyy mikrotrubochkovyy ingibitor dlya lecheniya metastaticheskogo raka molochnoy zhelezy
Stenina M.B.
Efficacy of ramucirumab in the second-line treatment of patients with disseminated gastric cancer in routine clinical practice in Russia (RAMSELGA observational study)
Besova N.S., Titova T.A., Tryakin A.A., Artamonova E.V., Stroyakovsky D.L., Perminova E.V., Yukalchuk D.Y., Ponomarenko D.M., Belyak N.P., Orlova R.V., Teletaeva G.M., Ratner E.Y., Mochalova A.S., Zhabina A.S., Gamayunov S.V., Smolin A.V., Povyshev A.Y., Andrievskikh M.I., Stilidi I.S.
Opyt kombinirovannogo lecheniya bol'nykh kolorektal'nym rakom s izolirovannymi metastazami v pecheni
Chernoglazova E.V., Vyshinskaya G.V., Sagaydak I.V., Rotobel'skaya L.E., Vorontsova K.A.
Nasopharyngeal cancer. ESMO 2024 news
Golubev P.V., Bolotina L.V., Kuzmina E.S., Pokataev I.A., Golubeva A.V., Kyanzhin E.P., Kuzmin V.M., Galkin V.N.
Modern approaches to the treatment of muscle-invasive bladder cancer
He Mingze -., Zeng Zitong -.
Rol' aflibertsepta v lechenii metastaticheskogo kolorektal'nogo raka
Meshcheryakov A.A.
Rol' gistologicheskogo i molekulyarnogo analiza v vybore metoda lecheniya nemelkokletochnogo raka legkogo pozdnikh stadiy
Vladimirova L.Y., Kit O.I., Sholokhova E.A.
Algorithm for diagnostics and systemic therapy of metastatic hormone-sensitive HER2-negative breast cancer
Dashyan G.A., Olchonova A.A., Dzhelyalov E.S., Akhmedov R.M., Sereda O.A., Vats A.B., Zhurov A.S., Shaikhelislamova L.F., Pushkaruk G.A., Belousov A.M.
Abemacyclib is a unique representative of the class of CDK4/6 inhibitors in the treatment of HR+/HER2- metastatic breast cancer
Grechukhina K.S., Vorontsova K.A., Kuko T.M., Prosvirnov A.A., Ganshina I.P., Lubennikova E.V., Kolyadina I.V., Zhukova L.G.
Structural and functional changes in the thyroid gland in the early and late periods after radiation therapy
Amergulov I.I., Pavlova M.G., Sych Y.P., Zhuravleva Y.R., Dolov M.M., Berdyklychev M.T., Dobrokhotova V.Z., Sannikova E.O., Trofimova O.P., Orlova M.V., Kuznetsova D.A., Bychkova N.M., Zaitseva N.A., Kandakova E.Y., Sotnikov V.M., Ryzhkova E.G., Fadeev V.V.
The role of cyclin-dependent kinase inhibitors in adjuvant therapy of breast cancer
Semiglazov V.F., Krivorotko P.V., Bekkeldiyeva N.B., Komyakhov A.V., Emelyanov A.S., Gorina A.O.
TREATMENT OF NON-SMALL CELL LUNG CANCER: THE NEXT STEP
Borisova E.B., Gutorov S.L., Abramov M.E.
Osobennosti klinicheskogo techeniya invazivnogo dol'kovogo raka molochnoy zhelezy
Borisova E.I., Vyshinskaya G.V., Gutorov S.L., Stepanchenko M.V.
Avastin (bevacizumab) in the treatment of tumors of the stomach and pancreas
Semenov N.N.
Neoadjuvant and postneoadjuvant treatment for triple negative breast cancer
Semiglazov V.F., Dzhelyalova M.A., Tseluyko A.I., Pesotsky R.S., Bessonov A.A., Semiglazova T.Y.
Novye vozmozhnosti ispol'zovaniya targetnoy terapii v lechenii nekotorykh solidnykh opukholey (po materialam ESMO-2014)
Dobrova N.V.
CAPECITABINE AND FLUOROURACIL IN THE TREATMENT OF COLORECTAL CANCER AND GASTRIC CANCER: ANALYSIS OF DIRECT COMPARATIVE STUDIES
Fedyanin M.Y., Tryakin A.A., Fedyanin M.Y., Tryakin A.A.
Assessing the risk of recurrence of luminal HER2-negative breast cancer and the possibility of intensifying adjuvant hormonal therapy to reduce the risk of progression
Gordeeva O.O.
Non-small lung cancer. Expanding therapeutic opportunities: pembrolizumab in a number of malignant tumors
Gutorov S.L., Borisova E.I., Abramov M.E., Lud A.N., Arutyunyan E.A.
Klinicheskiy sluchay uspeshnogo lecheniya erilibulinom metastaticheskogo raka molochnoy zhelezy
Limareva S.V., Laytsan K.Y., Stroyakovskiy D.L., Demidova I.A., Gorbunova V.A.
Analysis of pharmacotherapy in patients with HR+HER2- metastatic breast cancer with PIK3CA mutations in real clinical practice
Fateeva A.V., Eliseeva E.V., Apanasevich V.I., Zaemskaya A.A.
Frequency and spectrum of PIK3CA mutations in hormone-dependent HER2-negative breast cancer: a single-center experience
Romashkina N.V., Klishina M.V., Karabina E.V.
Prospective randomized phase III trial comparing FOLFIRINOX and mFOLFOX6 as first-line treatment for patients with disseminated gastric cancer: interim assessment of tolerability and toxicity
Gavrilova D.A., Besova N.S., Obarevich E.S., Makiev G.G., Tryakin A.A., Stilidi I.S.
Type 3 diabetes mellitus: is there a chance to become famous?
Morgunov L.Y.
Hope or error: can combinations of EGFR tyrosine kinase inhibitors and other drugs replace monotherapy?
Moiseenko F.V.
The use of panitumumab in the treatment of chemoresistant metastatic sigmoid colon adenocarcinoma: a clinical case
Protsenko S.A., Teletaeva G.M., Degtyareva E.A., Semenova A.I., Latipova D.K., Novik A.V.
The combination of gemcitabine and nab-paclitaxel in patients with locally advanced and advanced pancreatic cancer
Vladimirova L.Y., Abramova N.A., Popova I.L., Novoselova K.A., Tikhanovskaya N.M., Ryadinskaya L.A., Lyanova A.A., Myagkova V.S., Teplyakova M.A., Storozhakova A.E., Kalabanova E.A., Samaneva N.Y., Kabanov S.N., Svetitskaya Y.V., Tishina A.V., Strakhova L.K., Yezhova M.O.
Pembrolizumab in the treatment of patients with non-small cell lung cancer and metastatic brain lesion: a clinical review
Vakhabova Y.V., Kolomeytseva A.A., Kalinin D.V., Kozak E.N., Fedenko A.A.
COMPARATIVE EVALUATION OF THE PROLIFERATIVE ACTIVITY OF CELLS OF KERATOACANTHOMA AND SQUAMOUS CELL SKIN CANCER
Kuntsevich Z.S., Gurevich L.E.
PROGNOSTIC SIGNIFICANCE OF THE E-CADHERIN EXPRESSION LEVEL IN PRIMARY TUMORS OF THE COLON IN PATIENTS WITH METASTATIC COLORECTAL CANCER, RECEIVED NEW CHEMOTHERAPY REGIMEN BASED ON TRIPLE COMBINATION: IRINOTECAN+OXALIPLATIN+CONTINUOUS-INFUSION 5-FLUOROURACIL AS A FIRST-LINE TREATMENT
Darenskaya A.D., Dobrova N.V., Khochenkov D.A., Stepanova E.V.
PD-L1 EXPRESSION IN BLADDER CANCER AGAINST THE BACKGROUND OF CHRONIC HERPESVIRUS INFECTION: RESULTS OF A PILOT STUDY
Kosova I.V., Loran O.B., Sinyakova L.A., Gundorova L.V., Kosov V.A., Pogodina I.E., Kolbasov D.N.
New possibilities of the treatment of breast cancer: microtubule inhibitors
Semiglazov V.F., Dashyan G.A., Krivorotko P.V., Paltuev R.M., Donskikh R.V., Semiglazova T.Y., Zernov K.Y., Gigolaeva L.P., Apollonova V.S.
Basic mechanisms of resistance to egfr tyrosine kinase egfrinhibitors
Sakaeva D.D., Gordiev M.G.
Eradication of Helicobacter pylori infection as a strategy for the prevention of stomach cancer: statements of MaastrichT-V consensus (2015)
Mayev I.V., Andreev D.N., Samsonov A.A., Dicheva D.T., Zaborovsky A.V., Partsvania-Vinogradova E.V.
PROSTATE-SPECIFIC ANTIGEN AS A CRITERION OF PROSTATE CANCER PROGRESSION AFTER RADICAL PROSTATECTOMY
Varlamov I.S., Varlamov S.A., Lazarev A.F.
APPLICATION OF REPLACEMENT THERAPY WITH PANCREATIN PREPARATIONS IN PATIENTS WITH PANCREATIC CANCER
Kucheryavy Y.A., Andreev D.N.
PLACE OF LAPATINIB IN THE THERAPY OF HER2-POSITIVE BREAST CANCER
Zhukova L.G., Ganshina I.P., Zaitsev V.G., Stepanchenko M.V.
Prognoz bol'nykh kolorektal'nym rakom pri ozhirenii
Solodkiy V.A., Chkhikvadze V.D., Stanoevich U.S., Dekhissi E.I.
H. PYLORI-INFEKTsIYa: SOVREMENNYE REKOMENDATsII PO DIAGNOSTIKE I LEChENIYu
Gratsianskaya A.N.
PERSPEKTIVY PRIMENENIYa S-1 V LEChENII BOL'NYKh RAKOM ZhELUDKA
Lud A.N., Abramov M.E., Meshcheryakov A.A.
NOVYE PERSPEKTIVNYE PREPARATY DLYa LEChENIYa HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY
Gorbunova V.A.
ROL' IMMUNOKON\"YuGATOV V TARGETNOY TERAPII ZLOKAChESTVENNYKh OPUKhOLEY
Semiglazov V.F., Dashyan G.A., Semiglazova T.Y., Paltuev R.M., Zernov K.Y., Pen'kov K.D., Grechukhina I.A., Semiglazov V.V.
Combined treatment of colorectal cancer patients with liver metastases
Polyakov A.N., Podluzhnyy D.V., Mamontov K.G., Borodin D.G., Patyutko Y.I.
Opyt primeneniya trastuzumaba v respublike Bashkortostan
Sakaeva D.D., Kunafina R.I., Popova E.V.
PRIMARY PREVENTION OF CERVICAL CANCER: PROGRESS AND PROSPECTS
Prilepskaya V.N., Bebneva T.N., Prilepskaya V.N., Bebneva T.N.
ADJUVANT CHEMOTHERAPY FOR COLON CANCER
Fedyanin M.Y., Tryakin A.A., Tyulyandin S.A., Fedyanin M.Y., Tryakin A.A., Tyulyandin S.A.
XELODA IN THE TREATMENT OF METASTATIC COLORECTAL CANCER
Dobrova N.V., Dobrova N.V.
Efficacy and safety of testosterone drugs in the treatment of hypogonadism in men
Gamidov S.I., Ovchinnikov R.I., Pavlovichev A.A., Tkhagapsoeva R.A., Gamidov S.I., Ovchinnikov R.I., Pavlovichev A.A., Thagapsoeva R.A.
Approaches to the diagnosis and treatment of patients with stage III–IV non-small cell lung cancer in Russia. Preliminary results of a retrospective multicenter non-interventional observational study
Reutova E.V., Laktionov K.K.
Trastuzumab deruxtecan in the treatment of breast cancer
Semiglazov V.F., Krivorotko P.V., Bekkeldieva N.B., Gorina A.O., Komyakhov A.V., Paltuev R.M., Tabagua T.T., Ereshenko S.S.
Reconstructive plastic surgery of the breast using autogenous tissue. Historical aspects
Khakimova S.G., Zikiryakhodzhaev A.D., Kaprin A.D., Khakimova G.G., Onofriychuk I.M., Rasskazova E.A., Sukhotko A.S., Vlasova M.Y., Bosieva A.R., Tokaev V.K.
Pelvic extrusion in patients with cervical cancer: clinical experience
Khakimov G.A., Khakimova G.G., Musurmonov K.U., Khakimova S.G., Orifjonova G.P.
Multiple thyroid carcinoma and other long-term endocrine consequences of chemoradiotherapy for medulloblastoma: a clinical case
Khruleva Y.I., Amergulov I.I., Likhodey N.V., Dzyuba A.S., Sych Y.P., Pavlova M.G.
Will our clinical practice change with the availability of new diagnostic methods, drug therapy and assessment of its effectiveness? Clinical case: hormone receptor-positive, HER2-negative metastatic breast cancer
Konstantinova M.M., Kuzina L.I.
Olaparib -modern approach to the treatment of BRCA-associated HER2-negative metastatic breast cancer. Clinical experience
Lubennikova E.V., Zhukova L.G., Gordeeva O.O., Drobot N.T., Kuznetsov A.V., Ganshina I.P.
The effectiveness of detoxification specialized nutrition for oncological diseases
Pilat T.L., Khanferyan R.A.
Experience of using a combination of gemcitabine and carboplatin in the treatment of metastatic collecting duct (Bellini) carcinoma
Sakaeva D.D., Kunafina R.I., Almukhametova G.M., Akchulpanov T.K.
Treatment of residual breast cancer
Ereschenko S.S., Semiglazov V.F., Krivorotko P.V., Dashyan G.A., Smirnova V.O., Komyakhov A.V., Gigolaeva L.P., Zhiltsova E.K.
Neoadjuvant and adjuvant chemohormonotherapy in patients with prostate cancer with high risk for progression
Ustinova T.V., Bolotina L.V., Kharchenko N.V., Paichadze A.A., Alekseev B.Y., Kornietskaya A.L., Isaeva K.M., Kachmazov A.A., Kaprin A.D., Fedenko A.A.
The predictive value of nutritional deficiency in the treatment of patients with locally advanced stomach cancer
Brish N.A., Semiglazova T.Y., Zakharova P.A., Mishchenko A.V., Kasparov B.S., Protsenko S.A., Teletaeva G.M., Latipova D.K., Semenova A.I., Tkachenko E.V., Alekseeva Y.V., Ulyanchenko Y.A., Filatova L.V., Semiglazov V.V.
Pharmacoeconomic analysis of pembrolizumab in combination with chemotherapy as the first line of advances non-squamous nonsmall cell lung cancer treatment
Zyryanov S.K., Frolov M.Y., Zhuravleva M.V., Rogov V.A., Sakaeva D.D.
PROSPECTIVE II PHASE STUDY ON THE EVALUATION OF THE EFFICACY OF MONOTHERAPY WITH CETUXIMAB AS THE FIRST-LINE TREATMENT FOR PATIENTS WITH METASTATIC COLORECTAL CANCER WITH WILD-TYPE KRAS, NRAS, AND BRAF GENES
Moiseenko V.M., Moiseenko F.V., Volkov N.M., Yanus G.A., Kuligina E.S., Sokolenko A.P., Aleksakhina S.N., Chubenko V.A., Kozyreva K.S., Abduloeva N.K., Kramchaninov M.M., Zhuravlev A.S., Khinshtein V.A., Shelekhova K.V., Kudryavtsev A.A., Myslik A.V., Ivantsov A.O., Venina A.R., Preobrazhenskaya E.V., Mityushkina N.V., Ievleva A.G., Imyanitov E.N.
EXPERIENCE OF USE OF NEOADJUVANT DOSE-INTENSIVE CHEMOTHERAPY WITH DOXORUBICIN AND CISPLATIN IN COMBINED TREATMENT OF LOCALLY ADVANCED CERVICAL CANCER: PROSPECTIVE SINGLE-CENTER NON-RANDOMIZED CONTROLLED STUDY
Smirnova O.A., Bondarev N.E., Petrova A.S., Guseinov K.D., Mikaya N.A., Artemyeva A.S., Gorodnova T.V., Nekrasova E.A., Lavrynovych O.E., Bashlyk V.O., Nyuganen A.O., Abramova A.V., Sidoruk A.A., Ulrikh E.A., Semiglazova T.Y., Urmancheeva A.F., Berlev I.V.
New molecular subtypes of non-small cell lung cancer and the possibilities of their treatment
Moiseenko F.V., Kudryavtsev A.A., Myslik A.V., Volkov N.M.
Neoadyavant therapy of non-small cell lung cancer: are there any perspectives?
Ragulin Y.A.
Possibilities of metabiotic therapy in the correction of gastrointestinal symptoms and violations of intestinal microbiota in patients with lung cancer during chemotherapy
Serkova M.Y., Avalueva E.B., Orlov S.V.
PRESSURIZED INTRAPERITONEAL AEROSOL CHEMOTHERAPY (PIAC) IN COMBINATION WITH SYSTEMIC CHEMOTHERAPY FOR STOMACH CANCER PATIENTS WITH PERITONEAL DISSEMINATION
Kaprin A.D., Khomyakov V.M., Ryabov A.B., Bolotina L.V., Ivanov A.V., Utkina A.B., Volchenko N.N.
CLINICAL CASE OF SUCCESSFUL TREATMENT OF METASTATIC COLORECTAL CANCER WITH ACHIEVEMENT OF COMPLETE PATHOMORPHOLOGICAL RESPONSE (FIRST LINE CHEMOTHERAPY)
Darenskaya A.D., Dobrova N.V., Zhukova L.G., Medvedeva B.M., Mochalnikova V.V.
NEOADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER
Semiglazov V.F., Semiglazov V.V., Dashyan G.A., Krivorotko P.V., Nikolaev K.S., Semiglazova T.Y., Komyakhov A.V., Bessonov A.A., Donskikh R.V., Paltuev R.M., Zernov K.Y.
Patogeneticheskaya lekarstvennaya terapiya preinvazivnykh neoplaziy sheyki matki
Bakhidze E.V., Berlev I.V., Arkhangel'skaya P.A.
O protivoopukholevom effekte preparatov vitamina D3: fundamental'nye issledovaniya i dokazatel'naya meditsina
Gromova O.A., Torshin I.Y., Malygin S.E., Limanova O.A., Gilel's A.V.
LAPATINIB PRI RAKE MOLOChNOY ZhELEZY
Fray I.V., Perevodchikova N.I.
METODOLOGIChESKIE ASPEKTY MORFOLOGIChESKOY DIAGNOSTIKI I OTsENKI LEChEBNOGO PATOMORFOZA TROYNOGO NEGATIVNOGO RAKA MOLOChNOY ZhELEZY
Andreeva Y.Y., Zavalishina L.E., Danilova N.V., Ilatovskaya M.E., Frank G.A.
Effektivnost' i bezopasnost' preparata Ekstimiya®, novogo pegilirovannogo filgrastima: rezul'taty otkrytogo sravnitel'nogo klinicheskogo issledovaniya II fazy patsientov s rakom molochnoy zhelezy, poluchayushchikh mielosupressivnuyu khimioterapiyu
Sheveleva L.P., Khorinko A.V., Burdaeva O.N., Nechaeva M.N., Matrosova M.P., Kovalenko N.V., Ivanov R.A., Chernovskaya T.V., Salafet O.V.
ChETYRE ASPEKTA AD\"YuVANTNOY TARGETNOY TERAPII HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY
Semiglazov V.F., Semiglazov V.V.
Strategies of development of programs of complex treatment of patients with primary unresectable locally advanced rectal cancer
Barsukov Y.A., Gordeev S.S., Fedyanin M.Y.
Effektivnost' i bezopasnost' ezhenedel'nogo vvedeniya paklitaksela bol'nym metastaticheskim rakom molochnoy zhelezy: rezul'taty prospektivnogo mnogotsentrovogo klinicheskogo issledovaniya
Stroyakovskiy D.L., Makhson A.N., Bolotina L.V., Gorbunova V.A., Koroleva L.A., Bagrova S.G., Borisova T.A., Kornietskaya A.L., Ivanov R.A., Nikitin K.D.
SESSMENT OF EFFECT OF VARIOUS SCHEMES OF HORMONAL THERAPY ON TESTOSTERONE LEVEL AND QUALITY OF LIFE OF PATIENTS WITH LOCALLY ADVANCED OR GENERALIZED PROSTATE CANCER
Sokov D.G., Rusakov I.G., Sokov D., Rusakov I.G.
ERECTILE DYSFUNCTION IN PATIENTS AFTER BRACHYTHERAPY FOR LOCALIZED PROSTATE CANCER: LITERATURE REVIEW
Gamidov S.o., Chepurov A.K., Perov R.A., Guseynov M.M., Gamidov S.I., Chepurov A.K., Perov R.A., Guseinov M.M.
TARGETED THERAPY OF BREAST CANCER (NEW DIRECTIONS)
Semiglazov V.F., Dashyan G.A., Semiglazov V.V., Paltuev R.M., Manikhas A.G., Bessonov A.A., Ermachenkova A.M., Shchedrin D.E., Tabagua T.T., Grechukhina I.A., Krivorot'ko P.V., Donskikh R.V., Semiglazova T.Y., Kolar'kova V.V., Semiglazo V.F., Dashyan G.A., Semiglazov V.V., Paltuev R.M., Manikhas A.G., Bessonov A.A., Yermachenkova A.M., Schedrin D.Y., Tabagua T.T., Grechukhina I.A., Krivorotko P.V., Donskih R.V., Semiglazova T.Y., Kolarkova V.V.
TARGET THERAPY HER2-POSITIVE BREAST CANCER WITH BRAIN METASTASES: NEW PROSPECTS FOR TREATMENT
Yu Semiglazova T., Filatova L.V., Kh Latipova D., Gershanovich M.L., Semiglazova T.Y., Filatova L.V., Khamidovna L.D., Gershanovich M.L.
Not just a prostate: problems of benign prostatic hyperplasia in elderly
Vertkin A.L., Rodyukova I.S., Galkin I.V., Arinina E.N., Vertkin A.L., Rodukova I.S., Galkin I.V., Arinina E.N.
Safety of continuous glycemic monitoring system in patients after total duodenopancreatectomy in the early postoperative period. Single-center retrospective cohort study
Farmanov A.G., Bublik E.V., Vinogradskaya O.I., Udovichenko O.V., Zilov A.V., Ryzhkova E.G., Egorov V.I., Fadeev V.V., Deunezheva S.M., Zhivov A.V., Tobianskaya I.E.
Ceritinib in the treatment of ALK-positive non-small cell lung cancer
Gordeeva O.O., Ivanova K.A., Meshcheryakov A.A.
Delay of initiation of adjuvant chemotherapy in patients with early breast cancer: causes and consequences
Dashyan G.A., Konstantinova V.V., Dzhelialov E.S., Akhmedov R.M., Semiletova Y.V., Zhurov A.S., Tyusenko A.E., Olchonova A.A., Pavlikova I.A., Belousov A.M.
Lorlatinib in the treatment of ALK-positive non-small cell lung cancer
Gordeeva O.O., Meshcheryakova N.A., Meshcheryakov A.A.
Pathological regression as an indicator of the effectiveness of perioperative FLOT/FOLFOX in patients with resectable gastric cancer
Belyak N.P., Orlova R.V., Kutukova S.I., Pelipas Y.V., Androsova A.V., Zhukova N.V.
Clinical case of treatment of patient with HRD-positive ovarian cancer
Khokhlova S.V.
Effectiveness of a shortened cycle of monoimmunotherapy in non-small cell lung cancer
Artemieva E.V., Moiseenko F.V., Volkov N.M., Egorenkov V.V., Abduloeva N.K., Bogdanov A.A., Zhabina A.S., Levchenko N.V., Moiseenko V.M.
New possibilities of neoadjuvant treatment of ER+ HER2- breast cancer in premenopausal patients
Orlova R.V., Vakhitova A.A., Gluzman M.I.
1 - 100 of 288 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"